3-Methoxy-4-(trifluoromethyl)benzaldehyde

Catalog No.: 
ACXLZC158
CAS No.: 
945003-38-3
Molecular Formula: 
C9H7F3O2
Molecular Weight: 
204.15
3-Methoxy-4-(trifluoromethyl)benzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$57.00In stockIn stock
5g98%$243.00In stockIn stock
10g98%$416.00In stockInquiry
25g98%$755.00In stockInquiry
100g98%$2336.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methoxy-4-(trifluoromethyl)benzaldehyde
IUPAC Name3-methoxy-4-(trifluoromethyl)benzaldehyde
MDL No.MFCD11110997
Molecular FormulaC9H7F3O2
Molecular Weight204.15
SMILESO=CC1=CC=C(C(F)(F)F)C(OC)=C1
InChI KeyXIRCMFYUQKUYJZ-UHFFFAOYSA-N
SynonymBenzaldehyde, 3-methoxy-4-(trifluoromethyl)-;1,8-Naphthyridine-2-acetonitrile,alpha-(3-chlorophenyl)-5,7-bis(trifluoromethyl)-(11CI)
CAS No.945003-38-3
PubChem CID17964170

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXLZC158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRQHX699 route compound structure diagram
    ACRQHX699447-93-8In Stock
  2. Then
  3. ACXLZC158 route product structure diagram
    ACXLZC158945003-38-3In Stock
Inquiry

2. ACXLZC158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKCZE480 route compound structure diagram
    ACKCZE480944805-63-4In Stock
  4. Then
  5. ACXLZC158 route product structure diagram
    ACXLZC158945003-38-3In Stock
Inquiry

3. ACXLZC158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXLZC158 route product structure diagram
    ACXLZC158945003-38-3In Stock
Inquiry

Comments (0)